Studies on digitalis. I. Direct effects on peripheral vascular resistance

The Journal of Clinical Investigation
J RossE Braunwald

Abstract

No abstract listed.

References

Dec 1, 1951·Proceedings of the Society for Experimental Biology and Medicine·R E SHIPLEY, C WILSON
Nov 27, 1948·British Medical Journal·J McMICHAEL

❮ Previous
Next ❯

Citations

Jan 1, 1984·European Journal of Clinical Pharmacology·G G BelzB Schneider
Jan 1, 1980·Intensive Care Medicine·P Herbert, J Tinker
Sep 1, 1976·Basic Research in Cardiology·W NechwatalT Eversmann
Sep 1, 1972·The American Journal of Digestive Diseases·L L Shanbour, E D Jacobson
Feb 1, 1968·The American Journal of Cardiology·M AkbarianW H Abelmann
May 28, 1985·European Journal of Pharmacology·R D Tanz, C A Fairfax
Jan 1, 1982·Pharmacology & Therapeutics·D B EvansH R Kaplan
Jan 1, 1982·Pharmacology & Therapeutics·K O Haustein
Jan 1, 1983·Pharmacology & Therapeutics·J P BourdariasJ Bardet
Jan 22, 1983·Lancet·H E de Wardener, G MacGregor
May 1, 1990·Journal of the American College of Cardiology·A C PowellW J Louis
May 1, 1985·Journal of the American College of Cardiology·E Braunwald
May 1, 1985·Journal of the American College of Cardiology·J C Longhurst, J Ross
Nov 8, 1973·The New England Journal of Medicine·T W Smith, E Haber
Feb 10, 1977·The New England Journal of Medicine·B LownC E Gaughan
Dec 1, 1996·Zentralblatt für Veterinärmedizin. Reihe A·A OryanM Maleki
Jul 1, 1962·The Journal of Clinical Investigation·R L KAHLERE BRAUNWALD
Jan 1, 1974·The Journal of Clinical Investigation·N P HamlinW J Powell
Dec 1, 1974·The Journal of Clinical Investigation·H GaranW J Powell
Aug 25, 2009·European Journal of Applied Physiology·Christophe JanssenPhilippe van de Borne
Nov 1, 1988·Journal of Pharmacological Methods·T S RaoS C Manchanda
Nov 1, 1973·Journal of Pharmaceutical Sciences·J S Bohrman, E B Thompson
Jul 1, 1976·American Heart Journal·P da LuzH Shubin
Jul 1, 1984·Progress in Cardiovascular Diseases·T W SmithJ D Marsh
May 1, 1984·Progress in Cardiovascular Diseases·T W SmithJ D Marsh
Mar 1, 1984·Progress in Cardiovascular Diseases·T W SmithJ D Marsh
May 1, 1969·Progress in Cardiovascular Diseases·D T MasonR Zelis
May 1, 1967·The American Journal of Cardiology·F E KlosterH E Griswold
Aug 1, 1969·American Heart Journal·J V Donlon, P N Yu
May 1, 1990·International Journal of Cardiology·M PetraskoV Kocandrle
Jun 1, 1982·Experimental and Molecular Pathology·K Miyai, W G Hardison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.